Combinations of Anti-GITR Antibody and CD28 Superagonist Induce Permanent Allograft Acceptance by Generating Type 1 Regulatory T Cells

The authors reported the combined use of a CD28 superagonist and anti–glucocorticoid-induced tumor necrosis factor receptor–related protein monoclonal antibody (G3c) to induce Tr1 cells in vivo.